|
SNX19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62636570877339E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21824772492118E-12 |
| Normal-vs-Stage2 |
1.013960E-04 |
| Normal-vs-Stage3 |
3.3539837573926E-13 |
| Normal-vs-Stage4 |
7.82596210058273E-13 |
| Stage1-vs-Stage2 |
1.491590E-01 |
| Stage1-vs-Stage3 |
2.968300E-02 |
| Stage1-vs-Stage4 |
1.540540E-03 |
| Stage2-vs-Stage3 |
7.500200E-03 |
| Stage2-vs-Stage4 |
1.236650E-03 |
| Stage3-vs-Stage4 |
3.306000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.88258347483861E-15 |
| Normal-vs-AfricanAmerican |
8.41830000000154E-05 |
| Normal-vs-Asian |
2.73620015533993E-10 |
| Caucasian-vs-AfricanAmerican |
5.283600E-01 |
| Caucasian-vs-Asian |
4.163400E-01 |
| AfricanAmerican-vs-Asian |
2.637800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.82682774358045E-12 |
| Normal-vs-Female |
1.65623070813581E-12 |
| Male-vs-Female |
3.633400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43910439120987E-11 |
| Normal-vs-Age(41-60Yrs) |
4.35207425653061E-14 |
| Normal-vs-Age(61-80Yrs) |
5.23169996213824E-09 |
| Normal-vs-Age(81-100Yrs) |
2.761600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.311600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.457800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.353200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.598800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.253800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.993800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.014100E-02 |
| Classical-VS-Follicular |
1.436390E-01 |
| Classical-VS-Other |
1.252180E-01 |
| Classical-VS-Normal |
7.55570050969823E-10 |
| Tall-VS-Follicular |
1.198460E-03 |
| Tall-VS-Other |
6.743000E-01 |
| Tall-VS-Normal |
8.23274781680539E-12 |
| Follicular-VS-Other |
3.615600E-03 |
| Follicular-VS-Normal |
1.50106999999844E-05 |
| Other-VS-Normal |
1.12830000009723E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82219827904851E-11 |
| Normal-vs-N1 |
3.14670511869508E-11 |
| N0-vs-N1 |
2.430000E-02 |
|
|
